193 related articles for article (PubMed ID: 29247214)
1. Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.
Raggi C; Gammella E; Correnti M; Buratti P; Forti E; Andersen JB; Alpini G; Glaser S; Alvaro D; Invernizzi P; Cairo G; Recalcati S
Sci Rep; 2017 Dec; 7(1):17667. PubMed ID: 29247214
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
3. Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.
Mancinelli R; Cutone A; Rosa L; Lepanto MS; Onori P; Pannarale L; Franchitto A; Gaudio E; Valenti P
Eur J Histochem; 2020 Oct; 64(4):. PubMed ID: 33131269
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.
Raggi C; Correnti M; Sica A; Andersen JB; Cardinale V; Alvaro D; Chiorino G; Forti E; Glaser S; Alpini G; Destro A; Sozio F; Di Tommaso L; Roncalli M; Banales JM; Coulouarn C; Bujanda L; Torzilli G; Invernizzi P
J Hepatol; 2017 Jan; 66(1):102-115. PubMed ID: 27593106
[TBL] [Abstract][Full Text] [Related]
5. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
[TBL] [Abstract][Full Text] [Related]
6. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma.
Panawan O; Silsirivanit A; Chang CH; Putthisen S; Boonnate P; Yokota T; Nishisyama-Ikeda Y; Detarya M; Sawanyawisuth K; Kaewkong W; Muisuk K; Luang S; Vaeteewoottacharn K; Kariya R; Yano H; Komohara Y; Ohta K; Okada S; Wongkham S; Araki N
Cancer Sci; 2023 Aug; 114(8):3230-3246. PubMed ID: 37026527
[TBL] [Abstract][Full Text] [Related]
8. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.
Jamnongkan W; Thanan R; Techasen A; Namwat N; Loilome W; Intarawichian P; Titapun A; Yongvanit P
Tumour Biol; 2017 Jul; 39(7):1010428317717655. PubMed ID: 28671021
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
[TBL] [Abstract][Full Text] [Related]
11. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.
Raggi C; Invernizzi P; Andersen JB
J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250
[TBL] [Abstract][Full Text] [Related]
12. FBXO31 sensitizes cancer stem cells-like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in cholangiocarcinoma.
Zhu Z; Zheng Y; He H; Yang L; Yang J; Li M; Dai W; Huang H
Liver Int; 2022 Dec; 42(12):2871-2888. PubMed ID: 36269678
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
14. Profiles of cancer stem cell subpopulations in cholangiocarcinomas.
Cardinale V; Renzi A; Carpino G; Torrice A; Bragazzi MC; Giuliante F; DeRose AM; Fraveto A; Onori P; Napoletano C; Franchitto A; Cantafora A; Grazi G; Caporaso N; D'Argenio G; Alpini G; Reid LM; Gaudio E; Alvaro D
Am J Pathol; 2015 Jun; 185(6):1724-39. PubMed ID: 25892683
[TBL] [Abstract][Full Text] [Related]
15. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
Wang M; Xiao J; Shen M; Yahong Y; Tian R; Zhu F; Jiang J; Du Z; Hu J; Liu W; Qin R
Int J Cancer; 2011 Jan; 128(1):72-81. PubMed ID: 20232394
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells.
Sangsuwannukul T; Supimon K; Sujjitjoon J; Phanthaphol N; Chieochansin T; Poungvarin N; Wongkham S; Junking M; Yenchitsomanus PT
Int Immunopharmacol; 2020 Dec; 89(Pt B):107069. PubMed ID: 33242709
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
